Bank of New York Mellon Corp cut its holdings in Cigna Corporation (NYSE:CI) by 1.9% during the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 2,342,835 shares of the health services provider’s stock after selling 45,504 shares during the period. Bank of New York Mellon Corp owned 0.95% of Cigna Corporation worth $437,969,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in CI. JPMorgan Chase & Co. lifted its holdings in Cigna Corporation by 40.8% in the second quarter. JPMorgan Chase & Co. now owns 4,088,728 shares of the health services provider’s stock valued at $684,413,000 after acquiring an additional 1,184,632 shares during the last quarter. FMR LLC lifted its holdings in Cigna Corporation by 6.7% in the second quarter. FMR LLC now owns 6,909,638 shares of the health services provider’s stock valued at $1,156,604,000 after acquiring an additional 432,978 shares during the last quarter. Arrowstreet Capital Limited Partnership lifted its holdings in Cigna Corporation by 4,082.8% in the second quarter. Arrowstreet Capital Limited Partnership now owns 438,231 shares of the health services provider’s stock valued at $73,355,000 after acquiring an additional 427,754 shares during the last quarter. Vanguard Group Inc. lifted its holdings in Cigna Corporation by 2.5% in the second quarter. Vanguard Group Inc. now owns 17,130,735 shares of the health services provider’s stock valued at $2,867,514,000 after acquiring an additional 424,469 shares during the last quarter. Finally, American Century Companies Inc. lifted its holdings in Cigna Corporation by 56.9% in the second quarter. American Century Companies Inc. now owns 1,140,341 shares of the health services provider’s stock valued at $190,882,000 after acquiring an additional 413,759 shares during the last quarter. Hedge funds and other institutional investors own 89.69% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This story was first reported by TheOlympiaReport and is the property of of TheOlympiaReport. If you are viewing this story on another publication, it was illegally stolen and reposted in violation of US & international copyright legislation. The correct version of this story can be read at https://theolympiareport.com/2017/11/15/cigna-corporation-ci-position-reduced-by-bank-of-new-york-mellon-corp.html.

Cigna Corporation (CI) traded down $0.47 during trading on Wednesday, hitting $197.14. The stock had a trading volume of 1,263,100 shares, compared to its average volume of 1,361,488. Cigna Corporation has a 1-year low of $131.03 and a 1-year high of $206.45. The company has a quick ratio of 0.39, a current ratio of 0.39 and a debt-to-equity ratio of 0.37. The stock has a market capitalization of $48,720.69, a price-to-earnings ratio of 19.04, a P/E/G ratio of 1.51 and a beta of 0.49.

Cigna Corporation (NYSE:CI) last posted its quarterly earnings data on Thursday, November 2nd. The health services provider reported $2.83 earnings per share for the quarter, topping analysts’ consensus estimates of $2.36 by $0.47. Cigna Corporation had a return on equity of 18.85% and a net margin of 5.74%. The business had revenue of $10.38 billion for the quarter, compared to analyst estimates of $10.17 billion. During the same quarter in the prior year, the company earned $1.94 earnings per share. The company’s revenue was up 5.1% on a year-over-year basis. equities research analysts expect that Cigna Corporation will post 10.34 EPS for the current year.

In other news, CAO Mary T. Hoeltzel sold 575 shares of the company’s stock in a transaction on Thursday, November 9th. The stock was sold at an average price of $197.03, for a total transaction of $113,292.25. Following the sale, the chief accounting officer now owns 2,499 shares of the company’s stock, valued at $492,377.97. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director William D. Zollars sold 1,232 shares of the company’s stock in a transaction on Wednesday, September 13th. The stock was sold at an average price of $187.23, for a total value of $230,667.36. The disclosure for this sale can be found here. Insiders have sold 2,054 shares of company stock worth $389,721 in the last ninety days. Corporate insiders own 1.30% of the company’s stock.

A number of research firms recently commented on CI. Zacks Investment Research cut Cigna Corporation from a “buy” rating to a “hold” rating in a report on Friday, November 10th. Citigroup Inc. upped their price objective on Cigna Corporation from $198.00 to $231.00 and gave the company a “buy” rating in a report on Friday, November 3rd. Morgan Stanley upped their price objective on Cigna Corporation from $195.00 to $223.00 and gave the company an “overweight” rating in a report on Friday, November 3rd. Jefferies Group LLC upped their price objective on Cigna Corporation from $221.00 to $231.00 and gave the company a “buy” rating in a report on Friday, November 3rd. Finally, Royal Bank Of Canada reiterated an “outperform” rating and issued a $220.00 price objective (up from $185.00) on shares of Cigna Corporation in a report on Friday, November 3rd. Three analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the company. Cigna Corporation currently has a consensus rating of “Buy” and an average price target of $201.50.

About Cigna Corporation

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Corporation (NYSE:CI).

Institutional Ownership by Quarter for Cigna Corporation (NYSE:CI)

Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.